Latest market price
20.06
-0.70-3.37%
OverviewShort InterestFilings
NAMSQT11NewAmsterdam Pharma Company N.V.·NASDAQ
20.06-3.37%

Latest SEC Filings

Form category
DescriptionFilingDocument
Oct 02, 20264Statement of changes in beneficial ownership
Sep 29, 20268-KCurrent report
Sep 22, 2026SC 13D/ABeneficial ownership statement (active, amended)
Sep 21, 20268-KCurrent report
Sep 15, 20264Statement of changes in beneficial ownership
Sep 09, 20264Statement of changes in beneficial ownership
Sep 03, 20264Statement of changes in beneficial ownership
Aug 25, 20264Statement of changes in beneficial ownership
Aug 14, 20268-KCurrent report
Aug 14, 20268-K/ACurrent report (amended)
Aug 14, 20263Initial statement of beneficial ownership
Aug 06, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 05, 20268-KCurrent report
Aug 05, 202610-QQuarterly report
Jul 24, 20268-KCurrent report
Jul 22, 20268-KCurrent report
Jul 22, 20264Statement of changes in beneficial ownership
Jun 24, 20264Statement of changes in beneficial ownership
Jun 05, 2026S-8Registration of employee benefit securities
Jun 04, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Jun 03, 20268-KCurrent report
May 27, 20264Statement of changes in beneficial ownership
May 14, 2026SC 13D/ABeneficial ownership statement (active, amended)
May 07, 202610-QQuarterly report
May 07, 20268-KCurrent report
#1 / 25 of 362
Page
▼
/ 15